Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

ORGANON PHARMA PTY LTD

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (148)
Cancellation by sponsor (19)
Prescription medicine evaluation (2)

Date

2025 (5)
2024 (1)
2023 (19)
2022 (5)
2021 (2)
2020 (1)
2019 (2)
2017 (1)
2016 (14)
2015 (20)
2014 (1)
2013 (21)
2012 (4)
2011 (2)
2010 (6)
2008 (2)
2007 (3)
2006 (5)
2005 (8)
2003 (1)
2002 (3)
2001 (8)
2000 (2)
1999 (5)
1998 (5)
1997 (4)
1996 (1)
1995 (1)
1993 (2)
1992 (4)
1991 (11)

Search

Sponsor content

169 result(s) found, displaying 11 to 20

RECAGON follitropin beta (rch) 900 IU solution for injection cartridge. (393993)

28 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RECAGON follitropin beta (rch) 900 IU solution for injection cartridge.
RECAGON follitropin beta (rch) 600 IU solution for injection cartridge (393992)

28 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RECAGON follitropin beta (rch) 600 IU solution for injection cartridge.
OLMESARTAN HCT - DSK 40/25 olmesartan medoxomil 40 mg and hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN HCT - DSK 40/12.5 olmesartan medoxomil 40 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN HCT - DSK 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 40/10/25 olmesartan medoxomil 40mg, amlodipine (as besilate) 10mg and hydrochlorothiazide 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 40/10/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 10mg + hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 40/5/25 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 20/5/12.5 olmesartan medoxomil 20mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.